UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Research and analysis of regulatory framework and harmonisation of repurposing

Farmacija, 2024-09, Vol.71 (8), p.1-7

2024

Volltextzugriff (PDF)

Awareness of healthcare professionals about risk minimization measures associated with COVID-19 vaccines: international cross-sectional study

Biotechnology, biotechnological equipment, 2023-08, Vol.37 (1)

2023

Volltextzugriff (PDF)

Physician's knowledge and experience with the off-label use of medicines

Biotechnology, biotechnological equipment, 2021-01, Vol.35 (1), p.111-116

2021

Volltextzugriff (PDF)

What does self-medication counseling in Bulgarian community pharmacies look like – a field study

Farmacija, 2020-11, Vol.67 (4), p.289-293

2020

Volltextzugriff (PDF)

Evaluation of the current status of the value-added pharmacy services and pharmacists’ attitude in Bulgaria

Farmacija, 2019-07, Vol.66 (2), p.79-83

2019

Volltextzugriff (PDF)

Analysis of primary outpatient data for off-label use of medicines in neurology

Farmacija, 2019-12, Vol.66 (4), p.165-170

2019

Volltextzugriff (PDF)

Pilot Study of Pharmacists' Attitudes towards and Expectations for Remuneration of Valueadded Pharmacy Services (VAPS) in Bulgaria

Folia medica (Plovdiv), 2020-06, Vol.62 (2), p.324-330

2020

Volltextzugriff (PDF)

Safety limitations of fluoroquinolones’ use

Macedonian pharmaceutical bulletin, 2020, Vol.66 (3), p.213-214

2020

Volltextzugriff (PDF)

Medicine packaging pictograms in the context of the electronic product information (ePI) proposal

European journal of hospital pharmacy. Science and practice, 2022-05, Vol.29 (3), p.121-122

2022

Volltextzugriff (PDF)

Approaches for regulation of the “off- label use” within the European Union

Macedonian pharmaceutical bulletin, 2020, Vol.66 (3), p.201-202

2020

Volltextzugriff (PDF)

Safety of Covid-19 vaccines: one-year post-marketing analysis

Macedonian pharmaceutical bulletin, 2022-12, Vol.68 (3), p.487-488

2022

Volltextzugriff (PDF)

Requirements and possibilities for reporting ADRs: a comparative analysis between Bulgaria and the Republic of North Macedonia

Macedonian pharmaceutical bulletin, 2022-12, Vol.68 (3), p.535-536

2022

Volltextzugriff (PDF)

Study of obligations defined in agreements between parties involved in clinical trials of medicinal products in Bulgaria

Medicinski glasnik, 2012-08, Vol.9 (2), p.383-387

2012

Volltextzugriff (PDF)

Study of clinical experience with different approaches to controlled ovarian hyperstimulation: a focus on safety and efficacy

European journal of hospital pharmacy. Science and practice, 2021-01, Vol.28 (1), p.33-37

2021

Volltextzugriff (PDF)

Regulatory Requirements for Food Supplements in the European Union and Bulgaria

Folia Medica, 2019-03, Vol.61 (1), p.41-48

2019

Volltextzugriff (PDF)

Ethnobotanical records of not yet documented therapeutic effects of some popular Bulgarian medicinal plants

Emirates Journal of Food and Agriculture, 2014-07, Vol.26 (7), p.647

2014

Volltextzugriff (PDF)

In-depth Assessment after 18 Months of Distance E-learning of Pharmacists in Bulgaria

Archives Of Pharmacy Practice, 2021-04, Vol.12 (2), p.12-16

2021

Volltextzugriff (PDF)

Safety Assessment of Newly Marketed Herbal Medicines-Methodological Approach (Ginkgo biloba Example in Bulgaria)

Journal of herbal pharmacotherapy, 2008-01, Vol.7 (3-4), p.239-257

2008

Volltextzugriff (PDF)

Pilot Study of Pharmacists' Attitudes towards and Expectations for Remuneration of Valueadded Pharmacy Services (VAPS) in Bulgaria

Folia medica (Plovdiv), 2020-01, Vol.62 (2), p.324-330

2020

Volltextzugriff (PDF)

THE ROLE OF PATIENTS AND MEDICAL SPECIALISTS IN ACHIEVING HIGHER LEVEL OF THERAPY COMPLIANCE- AN EXAMPLE WITH WILLINGNESS TO PARTICIPATE IN CLINICAL TRIALS

CBU International Conference Proceedings, 2016, Vol.4, p.767-772

2016

Volltextzugriff (PDF)

Analysis of marketing authorization procedures with negative opinion 2020-2021 – how EMA handled challenges in drug therapy during Covid-19 pandemic

Annual for Hospital Pharmacy, 2021-10, Vol.7 (1), p.13

2021

Volltextzugriff (PDF)

Marketing authorization procedures with negative opinion from EMA—tendencies and novelties in 2021–2022

Annual for Hospital Pharmacy, 2022-10, Vol.8 (1), p.11

2022

Volltextzugriff (PDF)

Patients attitude about generics -Bulgarian perspective

Marmara pharmaceutical journal, 2012-01, Vol.1 (16), p.36-40

Lebanova, Hristina

2012

Volltextzugriff (PDF)

Risk-Minimization Measures in the EU: Review of Two Year Period Safety Referral Procedures

Saudi Journal of Medical and Pharmaceutical Sciences, 2020-06, Vol.6 (6), p.429-434

2020

Volltextzugriff (PDF)

Model Pharmacoeconomic Study on Iressa® (Gefitinib) as a First Line Treatment of Non-Small Cell Lung Cancer at Stage IIIB/IV in EGFR Mutation Positive Bulgarian Patients

Biotechnology, biotechnological equipment, 2013-01, Vol.27 (1), p.3586-3594

2013

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaBevacizumab

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(41)
Tagungsberichte
(1)

Sprache

Englisch
(41)
Türkisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Pharmacology & Pharmacy
(10)
Humans
(6)
Bulgaria
(5)
Patients
(4)
Pharmacovigilance
(4)
Biotechnology & Applied Microbiology
(3)
Medical Research
(3)
Medicine
(3)
Pharmacists
(3)
Physicians
(3)
Surveys
(3)
Age
(2)
Coronaviruses
(2)
Covid-19
(2)
Decision Making
(2)
Drug Stores
(2)
Economics
(2)
European Union
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Research and analysis of regulatory framework and harmonisation of repurposing

Awareness of healthcare professionals about risk minimization measures associated with COVID-19 vaccines: international cross-sectional study

Physician's knowledge and experience with the off-label use of medicines

What does self-medication counseling in Bulgarian community pharmacies look like – a field study

Evaluation of the current status of the value-added pharmacy services and pharmacists’ attitude in Bulgaria

Analysis of primary outpatient data for off-label use of medicines in neurology

Pilot Study of Pharmacists' Attitudes towards and Expectations for Remuneration of Valueadded Pharmacy Services (VAPS) in Bulgaria

Safety limitations of fluoroquinolones’ use

Medicine packaging pictograms in the context of the electronic product information (ePI) proposal

Approaches for regulation of the “off- label use” within the European Union

Safety of Covid-19 vaccines: one-year post-marketing analysis

Requirements and possibilities for reporting ADRs: a comparative analysis between Bulgaria and the Republic of North Macedonia

Study of obligations defined in agreements between parties involved in clinical trials of medicinal products in Bulgaria

Study of clinical experience with different approaches to controlled ovarian hyperstimulation: a focus on safety and efficacy

Regulatory Requirements for Food Supplements in the European Union and Bulgaria

Ethnobotanical records of not yet documented therapeutic effects of some popular Bulgarian medicinal plants

In-depth Assessment after 18 Months of Distance E-learning of Pharmacists in Bulgaria

Safety Assessment of Newly Marketed Herbal Medicines-Methodological Approach (Ginkgo biloba Example in Bulgaria)

Pilot Study of Pharmacists' Attitudes towards and Expectations for Remuneration of Valueadded Pharmacy Services (VAPS) in Bulgaria

THE ROLE OF PATIENTS AND MEDICAL SPECIALISTS IN ACHIEVING HIGHER LEVEL OF THERAPY COMPLIANCE- AN EXAMPLE WITH WILLINGNESS TO PARTICIPATE IN CLINICAL TRIALS

Analysis of marketing authorization procedures with negative opinion 2020-2021 – how EMA handled challenges in drug therapy during Covid-19 pandemic

Marketing authorization procedures with negative opinion from EMA—tendencies and novelties in 2021–2022

Patients attitude about generics -Bulgarian perspective

Risk-Minimization Measures in the EU: Review of Two Year Period Safety Referral Procedures

Model Pharmacoeconomic Study on Iressa® (Gefitinib) as a First Line Treatment of Non-Small Cell Lung Cancer at Stage IIIB/IV in EGFR Mutation Positive Bulgarian Patients

Aktive Filter

Suchergebnisse filtern